Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.11
Delayed Data
As of Dec 03
 -0.20 / -6.04%
Today’s Change
1.86
Today|||52-Week Range
9.54
-12.64%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +92.93% increase from the last price of 3.11.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.00%
 
 
 
 
 
 
Growthannually -396.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.